dc.contributor.author | Gungor, Baris | |
dc.contributor.author | Isleyen, Hasan Burak | |
dc.contributor.author | Okuyan, Ertugrul | |
dc.contributor.author | Yildirim, Mehmet Rifat | |
dc.contributor.author | Sahin, Irfan | |
dc.contributor.author | Barman, Hasan Ali | |
dc.contributor.author | Kahyaoglu, Serdar | |
dc.contributor.author | DURMAZ, Eser | |
dc.contributor.author | Atici, Adem | |
dc.contributor.author | Gulsen, Kamil | |
dc.contributor.author | Tugrul, Sevil | |
dc.date.accessioned | 2021-03-03T08:23:15Z | |
dc.date.available | 2021-03-03T08:23:15Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Barman H. A. , Kahyaoglu S., DURMAZ E., Atici A., Gulsen K., Tugrul S., Isleyen H. B. , Yildirim M. R. , Gungor B., Okuyan E., et al., "The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction", CORONARY ARTERY DISEASE, cilt.31, sa.1, ss.7-12, 2020 | |
dc.identifier.issn | 0954-6928 | |
dc.identifier.other | av_173efc63-9b85-4433-8925-e6a1835966cf | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/20982 | |
dc.identifier.uri | https://doi.org/10.1097/mca.0000000000000781 | |
dc.description.abstract | This study was performed to evaluate the relationship between the CHA(2)DS(2)-VASc score and no-reflow (NR) phenomena in patients with non-ST-segment elevation myocardial infarction (NSTEMI). A total number of 428 consecutive patients with NSTEMI were assessed for this study. Patients were divided into 2 groups, those with NR, NR(+) (n=84), and those without NR, NR(-) (n=307), according to their post-PCI, no-reflow status. The CHA(2)DS(2)-VASc score was significantly higher in the NR(+) group compared to the NR(-) (3.48 +/- 1.19 vs 1.81 +/- 0.82,P< 0.001). After a multivariate regression analysis, a higher CHA(2)DS(2)-VASc score (OR: 6.52, 95% CI: 3.51-12.14,P< 0.001), hs-Troponin (OR: 1.077, 95% CI: 1.056-1.099,P<0.001) and TTG (OR: 1.563, 95% CI: 1.134-2.154,P=0.006) were independent predictors of NR. CHA(2)DS(2)-VASc score is associated with higher risk of no-reflow in patients with NSTEMI undergoing PCI. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Kardiyoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.title | The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction | |
dc.type | Makale | |
dc.relation.journal | CORONARY ARTERY DISEASE | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 31 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 7 | |
dc.identifier.endpage | 12 | |
dc.contributor.firstauthorID | 2276626 | |